Point Prevalence Survey of Palliative Care Needs in Hospitals and Residential Care Facilities for the Elderly.
NCT ID: NCT07313748
Last Updated: 2026-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
3000 participants
OBSERVATIONAL
2025-11-01
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of Elderly Patients in Need of Palliative Care by Family Physicians
NCT04010136
Survey on Palliative Care and Law Perception
NCT06245525
Advanced Dementia and End-of-life
NCT03548142
IssuEs in Palliative Care for People in Advanced and Terminal Stages of Young-onset and Late-Onset Dementia in GErmany
NCT03364179
PALLIATIVE ASSESSMENT COHORT IN THE GERIATRIC EMERGENCY SETTING
NCT06911411
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study aims to measure the prevalence of palliative care needs among adults admitted to Internal Medicine and Geriatrics wards and among residents of participating long-term care facilities on 11 November. Assessment will be performed using a purpose-designed questionnaire. The study intends to: (1) generate a detailed estimate of palliative care needs in hospital and residential settings; (2) increase awareness among healthcare professionals and promote timely identification and management of palliative care needs; and (3) highlight the relevance of a palliative approach not only in traditional palliative care services (hospice, home-based palliative care) but also within hospitals and long-term care facilities.
A point-prevalence (cross-sectional) design will be used through administration of a web-based survey.
Sample
Inclusion criteria
Participants must meet all of the following:
* age ≥18 years;
* hospitalised in participating wards or residing in participating long-term care facilities (medicalised nursing homes: RSA Medicalizzata, R2, R2D, R3) on 11 November;
* able to provide written informed consent and consent for data processing, or oral consent supported by a relative, caregiver, or proxy.
Exclusion criteria Participants will be excluded if they are unable to provide written consent or supported oral consent for participation and data processing.
Questionnaire
Palliative care needs will be assessed using a dedicated questionnaire (Appendix 1), delivered via a web platform. The instrument comprises three sections:
Facility-level data:
* region;
* ward type (Internal Medicine, Geriatrics) or care model for long-term facilities;
* number of beds and number of eligible patients;
* availability of an in-house palliative care service (hospitals) or access to specialist palliative consultation (long-term care).
Rater characteristics:
* socio-demographic data (age group, sex);
* profession, years of experience, current or completed specialty training.
Patient-level data:
* socio-demographic variables (age, sex);
* comorbidities (Charlson Comorbidity Index);
* mobility (baseline and current functional status);
* daily nutritional intake and recent decline;
* dysphagia (presence and type);
* pressure ulcers (including stage III-IV lesions);
* palliative care indicators (NECPAL);
* pain assessment (Numeric Pain Rating Scale, or PAINAD for advanced dementia);
* delirium screening (4AT).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to participating Internal Medicine or Geriatrics wards or resident in participating long-term care facilities for older adults (medicalised nursing homes: RSA Medicalizzata, R2, R2D, R3) on 11 November (National Palliative Care Day)
* Able to provide: written informed consent for study participation and data processing, or oral consent supported by a relative/caregiver/legal proxy
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Graziano Onder
Role: PRINCIPAL_INVESTIGATOR
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, Rome, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Roma, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8190
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.